US › Healthcare

CERo Therapeutics Holdings, Inc. Common Stock (CERO)

US · Healthcare · Biotechnology

$0.01+30.00%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.0M

EPS

$-9.10

EPS estimate

$-4.35

EPS came in at -9.10 against a street estimate of -4.35 — a miss of 109.2%.

Key statistics

Market cap

$859,571

P/E

0.0

Forward P/E

0.0

P/B

0.00

Book value

$-0.50

EPS (TTM)

$84.10

52-week high

$5.72

52-week low

$0.01

50-day MA

$0.01

200-day MA

$0.04

Beta

0.21

Analyst view

Analysts rate CERo Therapeutics Holdings, Inc. Common Stock a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $30.00.

Shareholding

Insiders

2.96%

Institutions

0.09%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CERo Therapeutics Holdings, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.